Chris Pasquale

Stock Analyst at Guggenheim

(0.36)
# 4,278
Out of 5,111 analysts
3
Total ratings
n/a
Success rate
-9.93%
Average return

Stocks Rated by Chris Pasquale

DexCom
Jan 7, 2022
Upgrades: Buy
Price Target: $145
Current: $66.37
Upside: +118.47%
The Cooper Companies
Jan 3, 2022
Upgrades: Buy
Price Target: $124
Current: $81.04
Upside: +52.70%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $45
Current: $35.66
Upside: +26.19%